Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems.

MLA

Manchanda, Ranjit, et al. “Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems.” Cancers, vol. 12, no. 7, July 2020, p. 1929. EBSCOhost, https://doi.org/10.3390/cancers12071929.

APA

Manchanda, R., Sun, L., Patel, S., Evans, O., Wilschut, J., De Freitas Lopes, A. C., Gaba, F., Brentnall, A., Duffy, S., Cui, B., Coelho De Soarez, P., Husain, Z., Hopper, J., Sadique, Z., Mukhopadhyay, A., Yang, L., Berkhof, J., & Legood, R. (2020). Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems. Cancers, 12(7), 1929. https://doi.org/10.3390/cancers12071929

Chicago

Manchanda, Ranjit, Li Sun, Shreeya Patel, Olivia Evans, Janneke Wilschut, Ana Carolina De Freitas Lopes, Faiza Gaba, et al. 2020. “Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems.” Cancers 12 (7): 1929. doi:10.3390/cancers12071929.